Compare Stocks

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADRO Aduro Biotech		$10.93	$4.51 ▼ $20.20	$236.61M	0.4	162,237 shs	171,500 shs
ATXI Avenue Therapeutics	$0.12 +20.6%	$0.15	$0.09 ▼ $1.25	$5.18M	-0.24	4.61 million shs	9.91 million shs
KIN Kindred Biosciences	$9.25	$9.22	$3.46 ▼ $9.28	$420.52M	1.3	840,890 shs	178,496 shs
NBSE NeuBase Therapeutics	$0.44 +4.7%	$0.68	$0.39 ▼ $4.80	$1.66M	0.83	202,576 shs	25,441 shs
TLC Taiwan Liposome	$7.00	$7.10	$4.07 ▼ $7.70	$294.54M	0.99	133,095 shs	12,421 shs

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADRO Aduro Biotech	0.00%	0.00%	0.00%	0.00%	0.00%
ATXI Avenue Therapeutics	-29.63%	-30.20%	-39.16%	-33.31%	-89.63%
KIN Kindred Biosciences	0.00%	0.00%	0.00%	0.00%	0.00%
NBSE NeuBase Therapeutics	0.00%	+0.26%	-57.44%	-32.12%	-83.97%
TLC Taiwan Liposome	0.00%	0.00%	0.00%	0.00%	0.00%

World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADRO Aduro Biotech	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATXI Avenue Therapeutics	0.8504 of 5 stars	0.0	5.0	0.0	4.6	1.4	0.0	0.0
KIN Kindred Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLC Taiwan Liposome	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADRO Aduro Biotech	N/A	N/A	N/A	N/A
ATXI Avenue Therapeutics	3.00	Buy	N/A	N/A
KIN Kindred Biosciences	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A
TLC Taiwan Liposome	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADRO Aduro Biotech	$17.26M	0.00	N/A	N/A	$4.07 per share	0.00
ATXI Avenue Therapeutics	N/A	N/A	N/A	N/A	$0.03 per share	N/A
KIN Kindred Biosciences	$42.16M	9.97	N/A	N/A	$1.75 per share	5.29
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A	$11.04 per share	N/A
TLC Taiwan Liposome	$3.63M	81.14	N/A	N/A	$0.83 per share	8.43

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADRO Aduro Biotech	-$82.37M	-$5.15	N/A	N/A	N/A	-230.92%	-101.73%	-22.35%	N/A
ATXI Avenue Therapeutics	-$10.38M	-$1.27	N/A	∞	N/A	N/A	N/A	-335.11%	5/10/2024 (Estimated)
KIN Kindred Biosciences	-$21.80M	-$0.55	N/A	N/A	N/A	-529.26%	-54.19%	-39.76%	N/A
NBSE NeuBase Therapeutics	-$4.37M	-$7.70	N/A	∞	N/A	N/A	-99.74%	-60.13%	5/9/2024 (Estimated)
TLC Taiwan Liposome	-$35.02M	-$0.88	N/A	N/A	N/A	-299.27%	-120.45%	-55.11%	N/A

Latest KIN, NBSE, ATXI, TLC, and ADRO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/18/2024	Q4 2023	ATXI Avenue Therapeutics	N/A	$0.56	+$0.56	$0.56	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADRO Aduro Biotech	N/A	N/A	N/A	N/A	N/A
ATXI Avenue Therapeutics	N/A	N/A	N/A	N/A	N/A
KIN Kindred Biosciences	N/A	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A	N/A
TLC Taiwan Liposome	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADRO Aduro Biotech	N/A	8.91	8.91
ATXI Avenue Therapeutics	N/A	1.55	1.55
KIN Kindred Biosciences	0.19	7.02	7.02
NBSE NeuBase Therapeutics	N/A	2.87	2.87
TLC Taiwan Liposome	0.67	3.01	3.01

Ownership

Institutional Ownership

Company	Institutional Ownership
ADRO Aduro Biotech	49.93%
ATXI Avenue Therapeutics	17.34%
KIN Kindred Biosciences	66.89%
NBSE NeuBase Therapeutics	12.37%
TLC Taiwan Liposome	0.22%

Insider Ownership

Company	Insider Ownership
ADRO Aduro Biotech	5.90%
ATXI Avenue Therapeutics	1.80%
KIN Kindred Biosciences	13.69%
NBSE NeuBase Therapeutics	13.90%
TLC Taiwan Liposome	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ADRO Aduro Biotech	152	16.21 million	N/A	Optionable
ATXI Avenue Therapeutics	3	44.26 million	43.46 million	Not Optionable
KIN Kindred Biosciences	63	45.46 million	N/A	Optionable
NBSE NeuBase Therapeutics	37	3.75 million	3.23 million	Not Optionable
TLC Taiwan Liposome	2,020	42.08 million	N/A	Not Optionable

KIN, NBSE, ATXI, TLC, and ADRO Headlines

Source	Headline
	Angela Deem accuses TLC of forcing her to 'keep her mouth shut' in unhinged rant msn.com - April 23 at 11:14 PM
	How to watch TLC’s ‘Little People, Big World’ new episodes free April 23 masslive.com - April 23 at 6:13 PM
	Why Kody Brown is the Most Disliked TLC Villain of All Time yahoo.com - April 21 at 12:36 PM
	'I end up pooping myself on stage,' man cries after botched weight loss surgery in new TLC show msn.com - April 19 at 10:23 AM
	‘7 Little Johnstons’ Season 14: How to watch episode 6 on TLC for free msn.com - April 16 at 7:23 PM
	Monday: ‘Seeking Sister Wife’ Season 5, episode 7: How to watch TLC online for free cleveland.com - April 15 at 7:49 PM
	See inside three-bed end terrace on sale for just £35k, but it needs serious TLC msn.com - April 15 at 9:47 AM
	The Disco Biscuits Nod To OutKast, TLC, Gucci Mane, & More In Atlanta [Video/Audio] liveforlivemusic.com - April 14 at 6:18 PM
	Rico Wade, legendary Atlanta producer who worked with OutKast and co-wrote TLC's 'Waterfalls,' dies at 52 msn.com - April 13 at 8:27 PM
	Rico Wade, TLC ‘Waterfalls’ Cowriter and Southern Rap Trailblazer, Dies at 52 thewrap.com - April 13 at 3:27 PM
	Morris continues new Brooks-TLC plea observertoday.com - April 12 at 8:34 AM
	TLC starts $27m upgrade australianageingagenda.com.au - April 11 at 8:17 PM
	TLC donates to Clatsop Animal Assistance dailyastorian.com - April 11 at 10:16 AM
	TLC Should Cancel ‘Sister Wives’ After Garrison Brown’s Suicide msn.com - April 10 at 6:46 PM
	How to watch TLC’s ‘Take My Tumor’ season 1, episode 2, stream for free pennlive.com - April 10 at 1:45 PM
	Crimestoppers seek tips on $500+ equipment theft from TLC Tree Service in Pana newschannel20.com - April 9 at 3:11 PM
	‘Seeking Sister Wife’ Season 5, episode 6: How to watch TLC online for free cleveland.com - April 8 at 7:40 PM
	How to watch TLC’s ‘Seeking Sister Wife’ new episode free Monday, April 8 masslive.com - April 8 at 7:40 PM
	'OutDaughtered' and 'Doubling Down With the Derricos' Finally Returning to TLC—See the Exclusive Teasers msn.com - April 8 at 2:39 PM
	TLC is coming to the 2024 Wisconsin State Fair, with Jordin Sparks opening the concert msn.com - April 8 at 2:39 PM
	Fans Rejoice as ‘OutDaughtered’ and ‘Doubling Down With the Derricos’ Set to Premiere New Seasons on TLC msn.com - April 8 at 2:39 PM
	2024 Wisconsin State Fair: TLC takes Main Stage yahoo.com - April 8 at 9:39 AM
	2024 Wisconsin State Fair: TLC takes Main Stage, Aug. 2 fox6now.com - April 8 at 9:39 AM
	Goonya Fighter: First-Aid Boxes and some TLC kotaku.com - April 7 at 8:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 3, 2024 6:20 AM
View Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
3 Key Stocks Helping to Drive the EV Race
April 12, 2024 9:25 AM
View 3 Key Stocks Helping to Drive the EV Race
How to Protect your Portfolio Against a Rising VIX
April 10, 2024 9:22 AM
View How to Protect your Portfolio Against a Rising VIX
This Underrated Natural Gas Stock Could Rally Double-Digits Soon
April 1, 2024 9:15 AM
View This Underrated Natural Gas Stock Could Rally Double-Digits Soon
3 Energy Stocks to Consider as the Sector Breaks Out
April 8, 2024 8:55 AM
View 3 Energy Stocks to Consider as the Sector Breaks Out

All Headlines

Company Descriptions

Aduro Biotech

NASDAQ:ADRO

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.

Avenue Therapeutics

NASDAQ:ATXI

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.

Kindred Biosciences

NASDAQ:KIN

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

NeuBase Therapeutics

NASDAQ:NBSE

NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Taiwan Liposome

NASDAQ:TLC

Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial